Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 76301-76350 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05577845
5-HT3 Receptor Antagonist (Ramosetron) vs Loperamide for the Treatment of Low Anterior Resection Syndrome(RALARS)
NA
Recruiting
212 participants
Started: Mar 27, 2023 · Completed: Dec 31, 2032
1 condition
1 sponsor
1 location
NCT05163301
Alcohol Research in HIV: Relapse Prevention
NA
Recruiting
150 participants
Started: Mar 27, 2023 · Completed: May 31, 2026
2 conditions
2 sponsors
1 location
NCT04755387
Ticagrelor De-escalation Strategy in AMI Patients
PHASE4
Recruiting
2,312 participants
Started: Mar 27, 2023 · Completed: Jan 31, 2028
1 condition
3 sponsors
1 location
NCT06148688
Effect of Digital Storytelling Intervention on Diabetes Self-Management in Pregnant Women With Gestational Diabetes
NA
Recruiting
42 participants
Started: Mar 27, 2023 · Completed: Dec 31, 2023
2 conditions
2 sponsors
1 location
NCT05872555
Side Effects of Psychiatric Medications - a Nested Case Control Cohort Historical Prospective Study
N/A
Active, not recruiting
22,777 participants
Started: Mar 26, 2023 · Completed: Jan 1, 2025
1 condition
1 sponsor
1 location
NCT05781438
Feasibility of an In-home Standing and Walking Intervention for Infants With and at High Risk of Cerebral Palsy
NA
Recruiting
8 participants
Started: Mar 26, 2023 · Completed: Dec 31, 2026
1 condition
3 sponsors
1 location
NCT05530421
Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma
PHASE2
Recruiting
33 participants
Started: Mar 26, 2023 · Completed: Mar 26, 2028
1 condition
2 sponsors
3 locations
NCT05547724
Interest of Virtual Reality for the Management of Hospitalized Pregnant Patients at Risk of Preterm Delivery
NA
Recruiting
120 participants
Started: Mar 26, 2023 · Completed: Feb 12, 2026
1 condition
1 sponsor
1 location
NCT05069428
Delirium Reduction With Ramelteon
PHASE4
Recruiting
506 participants
Started: Mar 26, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05786586
650nm Low-level Red-light for Myopia Control and Prevention in Children
NA
Active, not recruiting
572 participants
Started: Mar 26, 2023 · Completed: Dec 31, 2026
1 condition
3 sponsors
1 location
NCT05950893
The Clinical Feasibility and Validity of PMIvent to Access Inspiratory Effort During Pressure Support Ventilation
NA
Recruiting
25 participants
Started: Mar 25, 2023 · Completed: Jan 31, 2025
1 condition
1 sponsor
1 location
NCT06495242
Direct Pulp Capping Compared to Partial Pulpotomy in Carious Pulp Exposures
NA
Active, not recruiting
120 participants
Started: Mar 25, 2023 · Completed: Dec 2, 2026
1 condition
2 sponsors
1 location
NCT06093737
Strengthening Community Mental Health
NA
Recruiting
300 participants
Started: Mar 25, 2023 · Completed: Jun 30, 2025
8 conditions
3 sponsors
1 location
NCT05783869
Study of Bronchiectasis and Associated Cardiovascular Comorbidities
N/A
Recruiting
30 participants
Started: Mar 25, 2023 · Completed: Nov 1, 2026
1 condition
2 sponsors
1 location
NCT05811273
Effect of Physical Readiness Training In Badminton Players
NA
Recruiting
24 participants
Started: Mar 25, 2023 · Completed: Jun 22, 2024
1 condition
1 sponsor
1 location
NCT05842148
Quality of Life After Conservative Oncoplastic Surgery in Breast Cancer Patients (IRONY: lIfe afteR ONcoplastic surgerY)
N/A
Recruiting
250 participants
Started: Mar 25, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05778981
Endothelial Dysfunction and Non-cardiac Surgery
N/A
Recruiting
200 participants
Started: Mar 25, 2023 · Completed: Dec 1, 2025
4 conditions
2 sponsors
1 location
NCT06036875
CARE: Cancer Risk Perception and Women of Color
N/A
Recruiting
550 participants
Started: Mar 25, 2023 · Completed: Feb 23, 2028
1 condition
1 sponsor
3 locations
NCT05842928
Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polypharmacy
NA
Recruiting
352 participants
Started: Mar 25, 2023 · Completed: Oct 31, 2026
6 conditions
8 sponsors
3 locations
NCT05080699
Evaluating Benefit of Peptide Based Diet in Obese HEN Patients
NA
Enrolling by invitation
12 participants
Started: Mar 25, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05242965
A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer
PHASE2
Active, not recruiting
5 participants
Started: Mar 24, 2023 · Completed: Dec 31, 2026
2 conditions
2 sponsors
2 locations
NCT06077617
Bedside Ultrasound Assessment of Feeding Tube Position in the Intensive Care Unit
N/A
Recruiting
423 participants
Started: Mar 24, 2023 · Completed: Jul 16, 2025
2 conditions
1 sponsor
1 location
NCT06476106
Human Research Program Flight Thigh Cuff
NA
Enrolling by invitation
10 participants
Started: Mar 24, 2023 · Completed: May 14, 2030
1 condition
1 sponsor
1 location
NCT05766254
Identify the Optimal TMS Target to Modulate Reward Activity
NA
Recruiting
36 participants
Started: Mar 24, 2023 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT05524428
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
NA
Recruiting
2 participants
Started: Mar 24, 2023 · Completed: Dec 31, 2024
1 condition
2 sponsors
4 locations
NCT05801276
ctDNA Methylation for Detecting Ovarian Cancer
N/A
Recruiting
1,400 participants
Started: Mar 24, 2023 · Completed: Mar 24, 2026
9 conditions
1 sponsor
1 location
NCT05892900
Transcutaneous Vagus Nerve Stimulation (tVNS) for Borderline Personality Disorder (tVNS-BPD)
NA
Recruiting
42 participants
Started: Mar 24, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05239546
Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers
PHASE2
Recruiting
25 participants
Started: Mar 24, 2023 · Completed: Jun 30, 2029
2 conditions
1 sponsor
1 location
NCT05827614
Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications
PHASE1
Recruiting
127 participants
Started: Mar 24, 2023 · Completed: Mar 31, 2027
12 conditions
1 sponsor
17 locations
NCT04484051
Growth Hormone Study in Adults With Prader-Willi Syndrome
N/A
Not yet recruiting
25 participants
Started: Mar 24, 2023 · Completed: Oct 1, 2026
1 condition
3 sponsors
1 location
NCT05923216
Induction of Sustained Unresponsiveness to Sesame Using High- and Low-dose Sesame Oral Immunotherapy
NA
Enrolling by invitation
40 participants
Started: Mar 24, 2023 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT05625659
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
NA
Recruiting
2,032 participants
Started: Mar 24, 2023 · Completed: Jan 1, 2027
1 condition
3 sponsors
10 locations
NCT05772455
A Study of XZB-0004 in Patients With Solid Tumors
PHASE1
Recruiting
128 participants
Started: Mar 24, 2023 · Completed: Feb 28, 2027
2 conditions
1 sponsor
1 location
NCT05742074
The Effect of Faecal Microbiota Transplantation (FMT) on Eradication of Multidrug Resistant Organisms (MRO) in Intestinal Carriers
NA
Recruiting
80 participants
Started: Mar 24, 2023 · Completed: Nov 30, 2028
2 conditions
4 sponsors
1 location
NCT05617963
Durvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the Thorax
PHASE2
Recruiting
100 participants
Started: Mar 24, 2023 · Completed: Feb 24, 2030
1 condition
2 sponsors
32 locations
NCT05801861
Modulating Goal-directed Navigation Using Noninvasive Brain Stimulation
NA
Recruiting
60 participants
Started: Mar 24, 2023 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT05894096
Air Cold Atmospheric Pressure Plasma Treatment for Acceleration of Venous Ulcer Healing
NA
Active, not recruiting
68 participants
Started: Mar 24, 2023 · Completed: Mar 30, 2025
1 condition
4 sponsors
5 locations
NCT05689645
F573 for Injection for the Treatment of Liver Injury/Failure
PHASE2
Recruiting
97 participants
Started: Mar 24, 2023 · Completed: Mar 31, 2026
2 conditions
1 sponsor
10 locations
NCT05545501
Ketone Ester and Acute Salt (KEAS) in Young Adults
NA
Recruiting
35 participants
Started: Mar 24, 2023 · Completed: Sep 30, 2026
2 conditions
4 sponsors
1 location
NCT05835999
Everolimus Aging Study
PHASE2
Recruiting
88 participants
Started: Mar 24, 2023 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT07119710
Telehealth to Improve Quality of Life in Persons Living in Rural Texas
NA
Recruiting
60 participants
Started: Mar 24, 2023 · Completed: Dec 1, 2028
2 conditions
1 sponsor
1 location
NCT05411081
Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial
PHASE2
Recruiting
200 participants
Started: Mar 24, 2023 · Completed: Jul 1, 2027
2 conditions
1 sponsor
200 locations
NCT05715216
EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer
PHASE2
Active, not recruiting
20 participants
Started: Mar 24, 2023 · Completed: Feb 8, 2026
1 condition
2 sponsors
1 location
NCT06622759
The Use of a Porcine Collagen Matrix for the Prevention of Buccal Bone Wall Resorption During Implant Placement in the Aesthetic Zone.
PHASE2
Recruiting
36 participants
Started: Mar 24, 2023 · Completed: Aug 30, 2025
1 condition
1 sponsor
1 location
NCT06586593
Neoadjuvant Immunotherapy of Operable Metastatic Melanoma in Real Life (GCC)
N/A
Recruiting
77 participants
Started: Mar 24, 2023 · Completed: Jan 31, 2025
1 condition
1 sponsor
9 locations
NCT05175300
Interest of a Highly Cross-linked Polyethylene Acetabular Component Doped With Vitamin E in Total Hip Arthroplasty of the Young and Active Subject
NA
Recruiting
100 participants
Started: Mar 24, 2023 · Completed: Mar 31, 2030
1 condition
1 sponsor
1 location
NCT05610085
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
PHASE2
Recruiting
133 participants
Started: Mar 24, 2023 · Completed: Dec 31, 2027
4 conditions
6 sponsors
4 locations
NCT05501873
Real World Data Collection in Subjects Treated With the FARAPULSE Pulsed Field Ablation System
N/A
Active, not recruiting
1,173 participants
Started: Mar 24, 2023 · Completed: Aug 15, 2027
1 condition
1 sponsor
48 locations
NCT05513872
Overcoming Nicotine Dependence to Enable Quitting
PHASE1/PHASE2
Recruiting
780 participants
Started: Mar 24, 2023 · Completed: Aug 30, 2027
5 conditions
2 sponsors
1 location
NCT05083247
Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma
PHASE2
Recruiting
256 participants
Started: Mar 24, 2023 · Completed: Dec 31, 2030
3 conditions
4 sponsors
10 locations
Previous
1
More pages
1524
1525
1526
1527
1528
1529
1530
More pages
2369
Next